• Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us
Credence Genomics Credence Genomics

Credence Genomics

  • Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us
banner-clinical-diagnosis

Clinical Diagnosis

At Credence, we are committed to introducing diagnostic tests that improve people’s lives.  We blend state-of- the-art technology with scientific excellence in generating clinically actionable, comprehensive diagnostic solutions to better understand human disease.

Our top priority

Patients are our top priority and we are dedicated to offer molecular diagnostic tests that provide essential information to help you answer your most pressing questions about disease, at every stage of your healthcare journey.

  • What’s my risk of developing a disease?
  • Am I affected?
  • Will I pass this down to my children?
  • How am I responding to current therapy?
  • How aggressive is my disease?

id3

Tests we offer

scientific-research

Our tests examine hundreds to thousands of critical changes or misspellings of the genetic code known as mutations in diagnosing a health status in question, enabling us to answer the patient’s most pressing questions about the disease.  Whether you are a patient, physician, healthcare provider or researcher, Credence helps in providing comprehensive, critical answers throughout the disease process.

Key points

  • Introducing the most advanced clinical diagnostic solutions
  • Highly experienced team and industry leader
  • Providing patients complete peace of mind
  • Reduced medical costs
  • Enabling patients a more productive and enjoyable life

Did you know?

With a team of experienced scientists and genetic counselors working around the clock to offer high quality services, we have become the industry leader in the diagnosis of genetically inherited diseases.

Get in touch

12-3/2 Sunethra Devi Road,
Kohuwala, Sri Lanka.

Phone: 011 2890687 / 011 2818370
Hotline: +94 71 038 0011
Email: info@credencegenomics.com

Search...

Call me back

Please fill out this form if you would want us to call you back.

captcha

Latest News Feed

https://www.credencegenomics.com/news/apollo-india-launches-dna-based-diagnostics-with-sri-lankas-credence-genomics/

Apollo India launches DNA based diagnostics with Sri Lanka’s Credence Genomics

December 3, 2017

Chennai – The Apollo Hospitals Group, India’s largest integrated... Read More

https://www.credencegenomics.com/news/eye-live-interview-dr-vaz-santosh-gnanam-ceo-director-credence-genomics/

EYE LIVE INTERVIEW DR. VAZ SANTOSH GNANAM – CEO / DIRECTOR – CREDENCE GENOMICS

December 2, 2017

Eye Live morning TV show interviewing Dr. Vaz Santosh... Read More

https://www.credencegenomics.com/news/bmc-infectious-diseases-publishes-credence-rid-bactfast-fungifast/

BMC Infectious Diseases publishes Credence RID, Bactfast & Fungifast

December 2, 2017

Credence Genomics Ltd., Sri Lanka’s premier specialised DNA diagnostics... Read More

News Archive

© Credence Genomics 2022. BenWorldwide | Feedback

Thank you

Your inquiry has been received.

Close